Jubilant Biosys seals deal with Pierre Fabre SA
Acquisition strengthens capabilities in biologics, ADCs, and integrated drug discovery
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Rusan Pharma Chairman Dr Navin Saxena receives Russia’s ‘Order of Friendship’ and ‘Memorial Medal’
Honours recognise contributions to science, medicine, and Indo-Russian collaboration
Glenmark Pharmaceuticals launches Latanoprost Ophthalmic Solution in the US
Latanoprost Ophthalmic Solution, 0.005 per cent introduced as a bioequivalent alternative to Xalatan
Machine learning model developed to predict brain amyloid beta accumulation
Oita University and Eisai introduce a model for primary care physicians to facilitate early screening for Alzheimer’s disease
ICT Mumbai and Mumbai Biocluster host 5th Annual Summit on Biopharmaceutical Product Development
The 5th Annual Biologics Conference, brought together over 700 attendees to discuss advancements in biopharma and biomanufacturing…
DKSH reports core EBIT growth and strong cash conversion in 2024
DKSH posts CHF 11.1 billion in net sales and reaffirms mid-term roadmap
AWS recognises Agilisium for Generative AI and Life Sciences Consulting competencies
Agilisium is among 13 global partners acknowledged for expertise in Generative AI and Life Sciences consulting
Axplora invests €50 million in Mourenx Site to expand API and biologics manufacturing
The investment will enhance peptide purification capabilities and support GLP-1 therapy production for diabetes and obesity…
Zydus Lifesciences signs agreement with Synthon BV for 505(B)(2) oncology product
Zydus to handle NDA submission and commercialisation in the US; Synthon to lead development and manufacturing
Pharma’s strategic path to growth in the nutra maze
The nutraceutical market is a thriving ecosystem of opportunities. For pharma companies, it’s a space where the allure of a $11.55…